Natural Product: NPC82955

Natural Product IDNPC82955
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Pseudo-Ginsenoside Rt
IUPAC Name (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms (24S)-Pseudo-Ginsenoside Rt4; Pseudo-Ginsenoside Rt
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL447942
PubChem CID 21633074
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001580] Triterpene glycosides
            • [CHEMONTID:0002358] Triterpene saponins

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PSOUXXNNRFNUAY-ICKHAABJSA-N
Standard InCHI InChI=1S/C36H62O10/c1-31(2)23(39)10-12-33(5)22-15-19(38)25-18(36(8)14-11-24(46-36)32(3,4)43)9-13-34(25,6)35(22,7)16-20(29(31)33)44-30-28(42)27(41)26(40)21(17-37)45-30/h18-30,37-43H,9-17H2,1-8H3/t18-,19+,20-,21+,22+,23-,24-,25-,26+,27-,28+,29-,30+,33+,34+,35+,36-/m0/s1
SMILES OC[C@H]1O[C@@H](O[C@H]2C[C@@]3(C)[C@]4(C)CC[C@@H]([C@H]4[C@@H](C[C@@H]3[C@@]3([C@@H]2C(C)(C)[C@@H](O)CC3)C)O)[C@]2(C)CC[C@H](O2)C(O)(C)C)[C@@H]([C@H]([C@@H]1O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   654.43 Volume:   667.775
?
Van der Waals volume.
Dense:   0.98 LogP:   2.1
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.508
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.911
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   31.0
TPSA:   169.3
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   7.0 Rings:   6.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.219 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.624 Fsp3:   1.0
MCE-18:   133.389
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.785 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.008
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.207 Promiscuous compounds:   0.24

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.04 MDCK Permeability:   -5.117
Pgp-inhibitor:   0.001 Pgp-substrate:   0.376
PAMPA:   0.997
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.004
20% Bioavailability (F20%):   0.191 30% Bioavailability (F30%):   0.389
50% Bioavailability (F50%):   0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.835 MRP1:   0.624
Plasma Protein Binding (PPB):   74.647% Volume Distribution (VD):   -0.437
Fu: 19.788%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.025
BSEP inhibitor:   0.022

ADMET: Metabolism

CYP1A2-inhibitor:   0.008 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.962 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.001
CYP3A4-inhibitor:   0.038 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.712
HLM stability:   0.016
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.786 Half-life (T1/2):  2.339

ADMET: Toxicity

hERG Blockers:  0.023 hERG Blockers (10um):  0.068
Human Hepatotoxicity (H-HT):  0.52 Drug-induced Liver Injury (DILI):  0.438
AMES Toxicity:  0.914 Rat Oral Acute Toxicity:  0.146
Maximum Recommended Daily Dose:  0.089 Skin Sensitization:  1.0
Carcinogencity:  0.495 Eye Corrosion:  0.0
Eye Irritation:  0.036 Respiratory Toxicity:  0.155
Drug-induced Neurotoxicity:  0.011 Ototoxicity:  0.973
Hematotoxicity:  0.79 Drug-induced Nephrotoxicity:  0.883
Genotoxicity:  0.694 RPMI-8226 Immunitoxicity:  0.14
A549 Cytotoxicity:  0.882 Hek293 Cytotoxicity:  0.622
BCF:   0.843
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.188
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.42
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.714
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25128 Panax vietnamensis Species Araliaceae Eukaryota n.a. Vietnamese n.a. PMID[11325227]
NPO28005 Panax japonicus Species Araliaceae Eukaryota n.a. n.a. n.a. PMID[12350149]
NPO28005 Panax japonicus Species Araliaceae Eukaryota Roots n.a. n.a. PMID[28006911]
NPO28005 Panax japonicus Species Araliaceae Eukaryota n.a. n.a. n.a. PMID[28202328]
NPO25128 Panax vietnamensis Species Araliaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO28005 Panax japonicus Species Araliaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO28005 Panax japonicus Species Araliaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28005 Panax japonicus Species Araliaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO25128 Panax vietnamensis Species Araliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28005 Panax japonicus Species Araliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT993 Cell line Hepatocyte Mus musculus Inhibition = 31.8 % PMID[22694318]
NPT993 Cell line Hepatocyte Mus musculus Inhibition = 91.5 % PMID[22694318]
NPT993 Cell line Hepatocyte Mus musculus Inhibition = 62.8 % PMID[22694318]
NPT993 Cell line Hepatocyte Mus musculus Activity = 13.6 % PMID[22694318]
NPT993 Cell line Hepatocyte Mus musculus Activity = 39.0 % PMID[17722904]
NPT993 Cell line Hepatocyte Mus musculus Activity = 26.8 % PMID[10650082]
NPT993 Cell line Hepatocyte Mus musculus IC50 = 74800.0 nM PMID[21146414]
NPT136 Cell line SK-N-SH Homo sapiens Activity = 91.4 % PMID[23013356]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT993 Cell line Hepatocyte Mus musculus Survival = 39.4 % PMID[22910038]
NPT993 Cell line Hepatocyte Mus musculus Survival = 57.2 % PMID[22694318]
NPT993 Cell line Hepatocyte Mus musculus Survival = 48.7 % PMID[22694318]
NPT32 Organism Mus musculus Mus musculus IC50 = 74800.0 nM PMID[29353722]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC82955 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8919 High Similarity NPC229801
0.8333 Intermediate Similarity NPC307167
0.7703 Intermediate Similarity NPC131466
0.7683 Intermediate Similarity NPC210759
0.7471 Intermediate Similarity NPC305418
0.7403 Intermediate Similarity NPC309425
0.7308 Intermediate Similarity NPC114874
0.7125 Intermediate Similarity NPC274833
0.6974 Remote Similarity NPC140446
0.6854 Remote Similarity NPC237071
0.6854 Remote Similarity NPC238796
0.6744 Remote Similarity NPC127801
0.6625 Remote Similarity NPC47566
0.6625 Remote Similarity NPC129372
0.6582 Remote Similarity NPC136816
0.6552 Remote Similarity NPC152584
0.65 Remote Similarity NPC472989
0.6484 Remote Similarity NPC203434
0.6444 Remote Similarity NPC208594
0.642 Remote Similarity NPC472899
0.642 Remote Similarity NPC472898
0.6375 Remote Similarity NPC7341
0.6286 Remote Similarity NPC64081
0.6265 Remote Similarity NPC472901
0.622 Remote Similarity NPC609286
0.6136 Remote Similarity NPC472252
0.6136 Remote Similarity NPC245280
0.6092 Remote Similarity NPC473020
0.6064 Remote Similarity NPC160816
0.6 Remote Similarity NPC231340
0.5946 Remote Similarity NPC474574
0.5761 Remote Similarity NPC16520
0.5761 Remote Similarity NPC211879
0.5761 Remote Similarity NPC189852
0.5761 Remote Similarity NPC155010
0.5732 Remote Similarity NPC66654
0.56 Remote Similarity NPC6931
0.5543 Remote Similarity NPC288694
0.5529 Remote Similarity NPC43912
0.5465 Remote Similarity NPC160734
0.5426 Remote Similarity NPC601606
0.5341 Remote Similarity NPC8431
0.5312 Remote Similarity NPC286969
0.5217 Remote Similarity NPC473199

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC82955 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data